Prevalence of tobacco consumption among pulmonary tuberculosis patients and its correlation with tuberculosis incidence: a systematic review and meta-analysis in the Indian context

Submitted: December 31, 2024
Accepted: January 9, 2025
Published: April 7, 2025
Abstract Views: 468
PDF_EARLY VIEW: 167
SUPPLEMENTARY MATERIAL: 7
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Tuberculosis (TB) and tobacco use are two intertwined public health challenges that significantly impact low- and middle-income countries, particularly India, which bears the highest global TB burden. Tobacco use exacerbates TB risk, progression, and treatment outcomes. Despite the established association, research on the prevalence of smoking and smokeless tobacco (SLT) use among pulmonary TB (PTB) patients in India remains limited. This systematic review and meta-analysis aim to estimate the prevalence of smoking and SLT use among PTB patients in India and evaluate the association between tobacco consumption and TB incidence and treatment outcomes. A systematic search was conducted across four databases (PubMed, Embase, Web of Science, and Scopus) for studies published up to September 30, 2024, adhering to PRISMA guidelines. Pooled prevalence estimates were calculated using random-effects models, and subgroup analyses examined variations by gender and treatment stage. Odds ratios (ORs) were used to assess the association between smoking and PTB. Sensitivity analyses and Egger’s test were conducted to evaluate heterogeneity and publication bias. A total of 27 studies (n=9593 subjects) were included. The pooled prevalence of smoking among PTB patients was 31% [95% confidence interval (CI): 25-36%], while SLT use was 19% (95% CI: 13-26%). PTB patients were 2.5 times more likely to be smokers than non-TB controls (OR=2.51, 95% CI: 1.36-4.62). Smoking prevalence was highest among newly diagnosed patients (42%) and predominantly observed among males (38%). High heterogeneity (I²>98%) was observed across studies. To conclude, tobacco use is highly prevalent among Indian PTB patients, significantly contributing to disease burden. Integrating tobacco cessation strategies into India’s National TB Elimination Program is critical to improving TB outcomes, reducing transmission, and addressing the dual burden of tobacco and TB.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

World Health Organization, International Union against Tuberculosis and Lung Disease. A WHO / the Union monograph on TB and tobacco control: joining efforts to control two related global epidemics. 2007. Available from: https://www.who.int/publications/i/item/WHO-HTM-TB-2007.390.
IHME. Smoking and tobacco. Available from: https://www.healthdata.org/research-analysis/health-risks-issues/smoking-and-tobacco. Accessed on 21/11/2024.
Wang EY, Arrazola RA, Mathema B, et al. The impact of smoking on tuberculosis treatment outcomes: a meta-analysis. Int J Tuberc Lung Dis 2020;24:170-5.
WHO, TISS, Government of India. Global adult tobacco - survey second round. Available from: https://ntcp.mohfw.gov.in/assets/document/surveys-reports-publications/Global-Adult-Tobacco-Survey-Second-Round-India-2016-2017.pdf. Accessed on: 28/12/2024.
Thakur JS, Garg R, Narain JP, Menabde N. Tobacco Use: A Major Risk Factor for Non Communicable Diseases in South-East Asia region. Indian J Public Health 2011;55:155-60.
Quan DH, Kwong AJ, Hansbro PM, Britton WJ. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev 2022;31:210252.
JBI. JBI critical appraisal tools. Available from: https://jbi.global/critical-appraisal-tools. Accessed on: 29/12/2024.
Agarwal A, Mahore R, Datta S, et al. A study on nutritional status and its effectiveness on adults with pulmonary tuberculosis in North Madhya Pradesh. J Adv Med Pract 2023;5:205.
Pradeepkumar AS, Thankappan KR, Nichter M. Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed. Int J Tuberc Lung Dis 2008;12:1139-45.
Marak B, Kaur P, Rao SR, Selvaraju S. Non-communicable disease comorbidities and risk factors among tuberculosis patients, Meghalaya, India. Indian J Tuberc 2016;63:123-5.
Thomas BE, Thiruvengadam K, Vedhachalam C, et al. Prevalence of pulmonary tuberculosis among the tribal populations in India. PLoS One 2021;16:e0251519.
Choudhury R, Shakya S, Yadav PK, Kumar H. Prevalence of addiction among tuberculosis patients. Medico-Legal Update.2020;20:185-90.
Rathee D, Arora P, Meena M, et al. Comparative study of clinico-bacterio-radiological profile and treatment outcome of smokers and nonsmokers suffering from pulmonary tuberculosis. Lung India 2016;33:507.
Deepak KG, Daivadanam M, Pradeepkumar AS, et al. Smokeless tobacco use among patients with tuberculosis in Karnataka: the need for cessation services. Natil Med J India 2012;25:142-5.
Dolla CK, Dhanaraj B, Chandrasekaran P, et al. Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: a community survey in Thirvallur District, south India. PLoS One 2021;16:e0247245.
Gupta RK, Gupta A, Jamwal DS, Suri SP. A socio-epidemiological study of tuberculosis in a rural area. J Med Educ Res 2002;4:119-22.
Gupte HA, Zachariah R, Sagili KD, et al. Integration of tobacco cessation and tuberculosis management by NGOs in urban India: a mixed-methods study. Public Health Action 2018;8:50-8
Gupta H, Mahajan S, Lal M, et al. Prevalence of tobacco consumption and smoking and its effect on outcome among microbiologically confirmed new pulmonary tuberculosis patients on daily regimen of DOTS in Amritsar city. J Family Med Prim Care 2022;11:2150-4.
Gambhir HS, Kaushik RM, Kaushik R, Sindhwani G. Tobacco smoking-associated risk for tuberculosis: a case-control study. Int Health 2010;2:216-22.
Jali MV, Mahishale VK, Hiremath MB, et al. Diabetes mellitus and smoking among tuberculosis patients in a tertiary care centre in Karnataka, India. Public Health Action 2013;3:51-3.
Kanakia KP, Majella MG, Thekkur P, et al. High tobacco use among presumptive tuberculosis patients, south India: time to integrate control of two epidemics. Osong Public Health Res Perspect 2016;7:228-32.
Kumar R, Kant S, Chandra A, Krishnan A. Tobacco use and nicotine dependence among newly diagnosed pulmonary tuberculosis patients in Ballabgarh tuberculosis unit, Haryana. J Family Med Prim Care 2020;9:2860-5.
Prasad R, Garg R, Singhal S, et al. A case-control tuberculosis in India. Ann Thorac Med 2009;4:208-10.
Bagchi S, Ambe G, Sathiakumar N. Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med 2010;1:223-32.
Das S, Basu M, Mandal A, et al. Prevalence and determinants of delay in diagnosis of pulmonary tuberculosis in Darjeeling district of West Bengal. J Family Med Prim Care 2017;6:627-35.
Saad T, Tirkey AS. Association between pulmonary tuberculosis and smoking: a case control study. Ind J Comm Health 2013;25:340-7.
Sumana M, Saraswathi S, Mukhopadhyay A, et al. Assessment of treatment outcomes of daily fixed-dose combination therapy among drug-sensitive pulmonary tuberculosis patients: A prospective study from Bengaluru, India. J Family Med Prim Care 2024;13:3129-34.
Thomas BE, Thiruvengadam K, S R, et al. Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored. PLoS One 2019;14:e0220507.
Mahishale V, Patil B, Lolly M, et al. Prevalence of smoking and its impact on treatment outcomes in newly diagnosed pulmonary tuberculosis patients: a hospital-based prospective study. Chonnam Med J 2015;51:86.
Mariappan VA, Sahu SK, Sarkar S, et al. Smoked and smokeless tobacco use among pulmonary tuberculosis patients under RNTCP in urban Puducherry, India. Indian J Tuberc 2016;63:158-66.
Rao VG, Bhat J, Yadav R, et al. Tobacco smoking: a major risk factor for pulmonary tuberculosis--evidence from a cross-sectional study in central India. Trans R Soc Trop Med Hyg 2014;108:474-81.
Rao VG, Bhat J, Yadav R, et al. Smoking and alcohol consumption: risk factors for pulmonary tuberculosis among the tribal community in central India. Indian J Tuberc 2017;64:40-3.
Rao VG, Bhat J, Yadav R, et al. A comparative study of the socio-economic risk factors for pulmonary tuberculosis in the Saharia tribe of Madhya Pradesh, India. Trans R Soc Trop Med Hyg 2018;112:272-8.
Bhat J, Rao VG, Sharma RK, et al. Investigation of the risk factors for pulmonary tuberculosis: a case–control study among: Saharia tribe in Gwalior district, Madhya Pradesh, India. Indian J Med Res 2017;146:97-104.
Brunet L, Pai M, Davids V, et al. High prevalence of smoking among patients with suspected tuberculosis in South Africa. Eur Respir J 2011;38:139-46.
Khan AH, Sulaiman SAS, Hassali MA, et al. Effect of smoking on treatment outcome among tuberculosis patients in Malaysia; a multicenter study. BMC Public Health 2020;20:854.
Marshall AM, Barua D, Mitchell A, et al. Smoking prevalence among tuberculosis patients: a crosssectional study in Bangladesh and Pakistan. Tob Induc Dis 2020;18:70.
Feldman C, Theron AJ, Cholo MC, Anderson R. Cigarette smoking as a risk factor for tuberculosis in adults: epidemiology and aspects of disease pathogenesis. Pathogens 2024;13:151.
Perriot J, Peiffer G, Underner M. Smoking and tuberculosis. Rev Prat 2024;74:526-8. [Article in French].
Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tob Induc Dis 2020;18:60.
Goyal LD, Verma M, Garg P, Bhatt G. Variations in the patterns of tobacco usage among indian females - findings from the global adult tobacco survey India. BMC Womens Health 2022;22:442.
Nayak G, Kavitha AK, Satpathy N, et al. Gendered pattern and predictors of tobacco use in India: evidence from the second round of global adult tobacco survey. Indian J Community Med 2023;48:241-9.
Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev 2018;27:170077.
Powers M, Sanchez TR, Welty TK, et al. Lung function and respiratory symptoms after tuberculosis in an American Indian population. The Strong Heart Study. Ann Am Thorac Soc 2020;17:38-48.
Safira N, Wichaidit W, Chongsuvivatwong V. The dynamic of smoking behavior through the course of tuberculosis illness: a hospital-based study in Medan, Indonesia. JR 2024;10:114-9.
Jeyashree K, Kathirvel S, Shewade HD, et al. Smoking cessation interventions for pulmonary tuberculosis treatment outcomes. Cochrane Database Syst Rev 2016;2016:CD011125.
Government of India. National framework for joint TB-tobacco collaborative activities. Available from: https://ntcp.mohfw.gov.in/assets/document/surveys-reports-publications/National-Framework-for-Joint-TB-Tobacco-Collaborative-Activities.pdf.

How to Cite

Debnath, Aninda, Ravindra Nath, Anubhav Mondal, Pankaj Chandrabhan Nathe, Jugal Kishore, Pranav Ish, Vidushi Rathi, and Jagdish Kaur. 2025. “Prevalence of Tobacco Consumption Among Pulmonary Tuberculosis Patients and Its Correlation With Tuberculosis Incidence: A Systematic Review and Meta-Analysis in the Indian Context”. Monaldi Archives for Chest Disease, April. https://doi.org/10.4081/monaldi.2025.3324.